PT67048A - Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen - Google Patents

Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen

Info

Publication number
PT67048A
PT67048A PT67048A PT6704877A PT67048A PT 67048 A PT67048 A PT 67048A PT 67048 A PT67048 A PT 67048A PT 6704877 A PT6704877 A PT 6704877A PT 67048 A PT67048 A PT 67048A
Authority
PT
Portugal
Prior art keywords
propanes
heterocyclyloxy
hydroxy
amino
preparation
Prior art date
Application number
PT67048A
Other languages
German (de)
English (en)
Other versions
PT67048B (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT67048A publication Critical patent/PT67048A/pt
Publication of PT67048B publication Critical patent/PT67048B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT67048A 1976-10-05 1977-09-19 Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen PT67048B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (2)

Publication Number Publication Date
PT67048A true PT67048A (de) 1977-10-01
PT67048B PT67048B (de) 1979-02-16

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67048A PT67048B (de) 1976-10-05 1977-09-19 Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen

Country Status (21)

Country Link
JP (1) JPS5350177A (pt)
AT (1) AT358037B (pt)
AU (1) AU514676B2 (pt)
BE (1) BE858867A (pt)
CA (1) CA1105021A (pt)
CH (1) CH607585A5 (pt)
DE (1) DE2740678A1 (pt)
DK (1) DK402877A (pt)
ES (1) ES462389A1 (pt)
FI (1) FI772681A (pt)
FR (1) FR2367065A1 (pt)
GB (1) GB1591723A (pt)
GR (1) GR71677B (pt)
IE (1) IE45692B1 (pt)
IL (1) IL53013A (pt)
NL (1) NL7710394A (pt)
NO (1) NO773125L (pt)
NZ (1) NZ185267A (pt)
PT (1) PT67048B (pt)
SE (1) SE7710250L (pt)
ZA (1) ZA775698B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
ES2038180T3 (es) * 1986-06-30 1993-07-16 Asahi Kasei Kogyo Kabushiki Kaisha Un procedimiento para preparar un compuesto que es un derivado de pirazina.
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
JPS5350177A (en) 1978-05-08
GB1591723A (en) 1981-06-24
PT67048B (de) 1979-02-16
FR2367065B1 (pt) 1980-10-10
IL53013A (en) 1981-09-13
ES462389A1 (es) 1978-07-01
FR2367065A1 (fr) 1978-05-05
ATA648777A (de) 1980-01-15
AU514676B2 (en) 1981-02-19
IE45692L (en) 1978-04-05
IE45692B1 (en) 1982-10-20
DE2740678A1 (de) 1978-04-06
ZA775698B (en) 1978-05-30
CA1105021A (en) 1981-07-14
GR71677B (pt) 1983-06-21
FI772681A (fi) 1978-04-06
AU2912577A (en) 1979-04-05
IL53013A0 (en) 1977-11-30
AT358037B (de) 1980-08-11
NO773125L (no) 1978-04-06
BE858867A (fr) 1978-03-20
NL7710394A (nl) 1978-04-07
DK402877A (da) 1978-04-06
SE7710250L (sv) 1978-04-06
NZ185267A (en) 1979-07-11
CH607585A5 (en) 1978-09-15

Similar Documents

Publication Publication Date Title
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
AT348509B (de) Verfahren zur herstellung von acylcyaniden
ATA706577A (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
DD131026A5 (de) Verfahren zur herstellung von methyldichlorphosphan
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
PT67048B (de) Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen
ATA312477A (de) Verfahren zur herstellung von cholecystokinin- -pancreozymin-octapeptidamid-sulfatester
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD134085A5 (de) Verfahren zur herstellung von halogenacylamiden
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD129792A5 (de) Verfahren zur herstellung von 1-oxadethiacephalosporinen
DD133797A5 (de) Verfahren zur herstellung von trans-5a-aryldecahydrobenzazepinen